Literature DB >> 10801999

Risk factors for syncope in a community-based sample (the Framingham Heart Study).

L Chen1, M H Chen, M G Larson, J Evans, E J Benjamin, D Levy.   

Abstract

The epidemiology of syncope has not been well described. Prior studies have examined risk factors for syncope in hospital-based or other acute or long-term care settings. To determine risk factors for syncope in a community-based sample, we performed a nested case-control study. We examined reports of syncope in Framingham Heart Study participants who underwent routine clinic visits from 1971 to 1990. For each syncope case (n = 543) 2 controls were matched for age, sex, and examination period. Mean age of subjects was 67 years (range 25 to 95); 59% were women. History of stroke or transient ischemic attack, history of myocardial infarction, high blood pressure, use of antihypertensive medication, use of other cardiac medication, smoking, alcohol intake, body mass index, systolic blood pressure, diastolic blood pressure, heart rate, atrial fibrillation, PR interval prolongation, interventricular block, and diabetes or elevated glucose level were examined as potential predictors. Using conditional logistic regression analysis, the predictors of syncope included a history of stroke or transient ischemic attack (odds ratio [OR] 2.56, 95% confidence interval [CI] 1.62 to 4.04), use of cardiac medication (OR 1.67, 95% CI 1.21 to 2. 30), and high blood pressure (OR 1.46, 95% CI 1.14 to 1.88). Lower body mass index was marginally associated with syncope (OR per 4 kg/m(2) decrement 1.10, 95% CI 0.99 to 1.22), as were increased alcohol intake (OR per 5 oz/week 1.11, 95% CI 0.99 to 1.26), and diabetes or an elevated glucose level (OR 1.29, 95% CI 0.96 to 1.75). To our knowledge, this study represents the first community-based study of risk factors for syncope.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10801999     DOI: 10.1016/s0002-9149(00)00726-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Short-term aerobic exercise reduces nitroglycerin-induced orthostatic intolerance in older adults with type 2 diabetes.

Authors:  Kenneth M Madden; Chris K Lockhart; Tiffany F Potter; Darcye J Cuff; Graydon S Meneilly
Journal:  J Cardiovasc Pharmacol       Date:  2011-06       Impact factor: 3.105

2.  Clinicians' guide to statistics for medical practice and research: part I.

Authors:  Marie A Krousel-Wood; Richard B Chambers; Paul Muntner
Journal:  Ochsner J       Date:  2006

3.  Hyperventilation-induced syncope: no need to panic.

Authors:  John E David; Steven H Yale; Humberto J Vidaillet
Journal:  Clin Med Res       Date:  2003-04

4.  Does the use of a syncope diagnostic protocol improve the investigation and management of syncope?

Authors:  D J Farwell; A N Sulke
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

5.  Syncope, Hypotension, and Falls in the Treatment of Hypertension: Results from the Randomized Clinical Systolic Blood Pressure Intervention Trial.

Authors:  Kaycee M Sink; Gregory W Evans; Ronald I Shorr; Jeffrey T Bates; Dan Berlowitz; Molly B Conroy; Deborah M Felton; Tanya Gure; Karen C Johnson; Dalane Kitzman; Mary F Lyles; Karen Servilla; Mark A Supiano; Jeff Whittle; Alan Wiggers; Lawrence J Fine
Journal:  J Am Geriatr Soc       Date:  2018-03-30       Impact factor: 5.562

6.  Cardiovascular safety profile of dapoxetine during the premarketing evaluation.

Authors:  Peter R Kowey; Ramagopal V Mudumbi; Joseph W Aquilina; Peter M DiBattiste
Journal:  Drugs R D       Date:  2011

7.  The Evaluation of Syncope in a Predominantly Black Population: Focus on Neuroimaging.

Authors:  Agazi G Gebreselassie; Delamo I Bekele; Yonette Paul; Julius S Ngwa; Daniel A Larbi
Journal:  N Am J Med Sci       Date:  2016-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.